Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,107 public trials 2,039 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

A Study Evaluating The Safety And Pharmacokinetics Of Escalating Doses Of RO7297089 In Patients With Relapsed Or Refractory Multiple Myeloma

NCT04434469

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Concord Repatriation General Hospital Concord, New South Wales, Australia
  • LIVERPOOL HOSPITAL; HAEMATOLOGY; Ingham Institute for Medical Research Liverpool, New South Wales, Australia
  • Royal Adelaide Hospital; Haematology Clinical Trials Adelaide, South Australia, Australia
  • St. Vincent's Hospital Melbourne Fitzroy, South Australia, Australia
View Trial Details
Completed

TJ202, Lenalidomide and Dexamethasone vs. Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

NCT03952091

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Capital Medical University (CMU) - Beijing Chao-Yang Hospital Beijing, Beijing Municipality, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Capital Medical University (CMU) - Beijing Chao-Yang Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Bengbu Medical college Bengbu, China
View all 41 locations
View Trial Details
Completed

A Study of Ixazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM)

NCT03439293

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Pacific Cancer Medical Center Anaheim, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • SCRI - Florida Cancer Specialists - Panhandle Tallahassee, Florida, United States
  • Research Medical Center - Kansas City Kansas City, Missouri, United States
View all 28 locations
View Trial Details
Completed

Study of TJ011133 in Participants With Relapsed/Refractory Advanced Solid Tumors and Lymphoma

NCT03934814

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • University of Alabama - Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • Yale School of Medicine New Haven, Connecticut, United States
  • Mayo Clinic Jacksonville, Florida, United States
View all 21 locations
View Trial Details
Completed

Study Evaluating the Safety and Pharmacokinetics of JCAR017 in B-cell Non-Hodgkin Lymphoma (TRANSCEND-NHL-001)

NCT02631044

Conditions
Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +15 more
Locations
  • Local Institution - 0006 Birmingham, Alabama, United States
  • Local Institution - 0007 Duarte, California, United States
  • Local Institution - 0010 San Francisco, California, United States
  • Local Institution - 0020 Aurora, Colorado, United States
View all 14 locations
View Trial Details

Related conditions